Alveolar type 2 progenitor cells for lung injury repair
2019年2月8日 · Alveolar type 2 progenitor cells (AT2) seem closest to clinical translation, specifying the evidence that AT2 may satisfactorily control the immune response to decrease...
241021 文献泛读 AT2 / AT1 - 知乎 - 知乎专栏
《Type 2 alveolar cells are stem cells in adult lung》，由Christina E. Barkauskas等人撰写，发表在《Journal of Clinical Investigation》上。 文章探讨了肺泡II型细胞（AEC2s）在成人肺中的 …
Tracing the origin of alveolar stem cells in lung repair and ...
2024年5月9日 · Using dual recombinase-mediated intersectional genetic approaches, Liu et al. find that alveolar stem cells (AT2 cells) are derived from existing AT2 cells, club cells, and …
Cell | 周斌团队发现成体肺泡干细胞的再生起源 - 知乎
2024年4月12日 · 近年来陆续有重要研究成果报道，发现在肺脏受损后，AT2细胞除了来源于自我更新外，还会起源于AT1细胞和club细胞 【2-6】，这些关于肺脏干细胞突破性的研究发现， …
Isolation and culture of mouse alveolar type II cells to study type II ...
2020年12月31日 · Alveolar type II cells (AT2) are stem cells of lung epithelium. To study these cells, we developed protocols to isolate primary AT2 and test the effects of potential niche …
"Dr. Jekyll and Mr. Hyde": AT2 Cells in Lung Regeneration and …
2025年3月24日 · Alveolar type II (AT2) cells, the primary stem cell population in the distal lung epithelium, are known to be the most common cell of origin for lung adenocarcinoma (LUAD). …
肺脏中的细胞-肺泡（mainly：AT1/ATI，AT2/ATII） - 简书
肺泡上皮主要由两种类型的上皮细胞组成：肺泡Ⅰ型（at1）和Ⅱ型（at2）细胞。at2 细胞是较小的立方体细胞，以其合成和分泌肺表面活性剂的功能而闻名。此外，at2 细胞作为肺泡干细胞， …
Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in ...
Alveolar epithelial type II cells (AT2) are a heterogeneous population that have critical secretory and regenerative roles in the alveolus to maintain lung homeostasis.
肺泡Ⅱ型上皮细胞功能的研究进展
肺泡Ⅱ-型上皮细胞(alveolar epithelial type Ⅱ cell,AT2)是构成哺乳类动物肺泡上皮的主要细胞之一,是合成和分泌肺泡表面活性物质的主要细胞。 近年来研究发现其合成和分泌功能受多种体液 …
Heterogeneous groups of alveolar type II cells in lung ... - PubMed
2020年12月1日 · The revelation of AT2 heterogeneity has brought new insights into the role of AT2 cells in various lung disease settings and potentiates the finding of more therapeutics …